Trials / Sponsors / Ji Dongmei
Ji Dongmei
Academic / Other · 2 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Cetuximab Combined With Pembrolizumab or Finotonlimab and Chemotherapy in R/M HNSCC Squamous Cell Carcinoma of Head and Neck | Phase 3 | 2026-04-01 |
| Recruiting | The Safety and Efficacy of MRG003 With or Without Putrelimab in Recurrent or Metastatic Salivary Gland Cancer: Salivary Gland Carcinomas | Phase 2 | 2026-03-19 |